Research Options:

Week of Expected Pricing 4/26/2021
Company Name TREACE MEDICAL CONCEPTS INC
Proposed Ticker TMCI
CUSIP 89455T109
Business Description A commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions). We have pioneered our proprietary Lapiplasty 3D Bunion Correction System – a combination of novel instruments, implants and surgical methods designed to improve the inconsistent clinical outcomes of traditional approaches to bunion surgery. Although bunions are deformities typically caused by an unstable joint in the middle of the foot that leads to a three-dimensional (3D) misalignment in the foot’s anatomical structure, the majority of traditional surgical approaches focus on correcting the deformity from a two-dimensional (2D) perspective and therefore fail to address the root cause of the disorder.
Lead Underwriter J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
Co-Managers Stifel Nicolaus & Company, Incorporated, SVB Leerink LLC
Initial Shares 93,75,000
Revised Initial Shares N/A
Initial Price $15.00-$17.00
Revised Price N/A
Final Price $17.00
Final Ticker TMCI

 

 

   
  © 2024 ICE Data Services. All rights reserved.